sleep apnea semaglutide Swallowable Balloon, Improve Obesity-Related OSA GLP-1 Medications Show Promise as

Therefore, while the Biden administrations proposed reinterpretation of Medicare Part D coverage of weight loss medications would allow for access to such therapies to approximately 3.4 million Medicare beneficiaries who have obesity, for budgetary reasons its unclear if the incoming Trump administration will go along with it

These medications mimic the effects of the glucagon-like peptide-1 (GLP-1) hormone, which regulates appetite and food intake

Ferrario CR, Laboube G, Liu S, Nieh EH, Routh VH, Xu S, OConnor EC

FGL plays a key role in supporting neuroprotection, improving memory retention, and facilitating neural repair